Onyx Biotec Limited (NSE:ONYX)

Onyx Biotec Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Revenue	600.07	537.49	394.82	448.61
Other Revenue	9.5	-	0.1	-
Revenue	609.58	537.49	394.92	448.61
Revenue Growth (YoY)	-	36.10%	-11.97%	-
Cost of Revenue	389.68	367.28	221.33	279.1
Gross Profit	219.9	170.21	173.59	169.51
Selling, General & Admin	76.24	60.13	105.03	86.56
Other Operating Expenses	28.15	26.96	23.1	25.69
Operating Expenses	134.94	109.59	143.05	126.72
Operating Income	84.96	60.62	30.54	42.79
Interest Expense	-26.34	-21.07	-5.65	-5.15
Interest & Investment Income	0.75	0.75	0.65	0.1
Currency Exchange Gain (Loss)	-	-	-0.01	-0
Other Non Operating Income (Expenses)	0.22	0.21	0.01	0.26
EBT Excluding Unusual Items	59.58	40.52	25.54	38
Gain (Loss) on Sale of Assets	-	-	-0.07	-0.05
Pretax Income	59.58	40.52	25.47	37.95
Income Tax Expense	15.41	10.2	7.02	4.42
Net Income	44.17	30.32	18.45	33.53
Net Income to Common	44.17	30.32	18.45	33.53
Net Income Growth	-	64.35%	-44.98%	-
Shares Outstanding (Basic)	13	12	12	12
Shares Outstanding (Diluted)	13	12	12	12
Shares Change (YoY)	8.08%	1.13%	-	-
EPS (Basic)	3.47	2.54	1.56	2.84
EPS (Diluted)	3.47	2.54	1.56	2.84
EPS Growth	-	62.81%	-45.07%	-
Free Cash Flow	-	-17.07	-165.01	-53
Free Cash Flow Per Share	-	-1.43	-13.98	-4.49
Gross Margin	36.07%	31.67%	43.95%	37.79%
Operating Margin	13.94%	11.28%	7.73%	9.54%
Profit Margin	7.25%	5.64%	4.67%	7.47%
Free Cash Flow Margin	-	-3.17%	-41.78%	-11.82%
EBITDA	115.33	83.12	45.45	57.27
EBITDA Margin	18.92%	15.46%	11.51%	12.77%
D&A For EBITDA	30.38	22.49	14.91	14.48
EBIT	84.96	60.62	30.54	42.79
EBIT Margin	13.94%	11.28%	7.73%	9.54%
Effective Tax Rate	25.86%	25.18%	27.57%	11.66%
Revenue as Reported	610.83	538.74	396.17	449.81
Advertising Expenses	-	0.06	0.09	0.03

Source: S&P Global Market Intelligence. Standard template. Financial Sources.